Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients

Savitri Krishnamurthy; Anthony Lucci

doi:10.1245/s10434-010-1421-5

Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	S263-S264
Journal	Annals of surgical oncology
Volume	18
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1245/s10434-010-1421-5
State	Published - Dec 2011

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-010-1421-5

Cite this

Krishnamurthy, S., & Lucci, A. (2011). Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Annals of surgical oncology, 18(SUPPL. 3), S263-S264. https://doi.org/10.1245/s10434-010-1421-5

Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. / Krishnamurthy, Savitri ; Lucci, Anthony.
In: Annals of surgical oncology, Vol. 18, No. SUPPL. 3, 12.2011, p. S263-S264.

Research output: Contribution to journal › Letter › peer-review

Krishnamurthy, S & Lucci, A 2011, 'Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients', Annals of surgical oncology, vol. 18, no. SUPPL. 3, pp. S263-S264. https://doi.org/10.1245/s10434-010-1421-5

Krishnamurthy S , Lucci A. Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Annals of surgical oncology. 2011 Dec;18(SUPPL. 3):S263-S264. doi: 10.1245/s10434-010-1421-5

Krishnamurthy, Savitri ; Lucci, Anthony. / Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. In: Annals of surgical oncology. 2011 ; Vol. 18, No. SUPPL. 3. pp. S263-S264.

@article{50bfee1531f84d48998b96e82551240c,

title = "Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients",

author = "Savitri Krishnamurthy and Anthony Lucci",

year = "2011",

month = dec,

doi = "10.1245/s10434-010-1421-5",

language = "English (US)",

volume = "18",

pages = "S263--S264",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "SUPPL. 3",

}

TY - JOUR

T1 - Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients

AU - Krishnamurthy, Savitri

AU - Lucci, Anthony

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=82955217661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955217661&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-1421-5

DO - 10.1245/s10434-010-1421-5

M3 - Letter

AN - SCOPUS:82955217661

SN - 1068-9265

VL - 18

SP - S263-S264

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - SUPPL. 3

ER -

Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this